Blog
IPO Express | New Ruipeng, a pet hospital from Shenzhen, is going for a US IPO and planning to list on the NASDAQ

On January 23 local time, New Ruipeng Pet Group Inc. (hereinafter referred to as "New Ruipeng"), the holding company of New Ruipeng Pet Medical Group Co., Ltd., officially filed an IPO application with the U.S. Securities and Exchange Commission (SEC), intending to list on the NASDAQ under the stock ticker RPET. Disclosures show that the company first submitted confidential documents to the SEC as early as June 17, 2021.
The prospectus has not yet disclosed information such as the offering size and offering price.
New Ruipeng conducts business through its Chinese subsidiary. The Shenzhen-based company was established in 2013, with its predecessor being Ruipeng Pet Hospital. It is a national chain operator of pet hospitals, with pet care services, supply chain services, and local services as its three pillars, and has expanded into other business areas including third-party diagnostics, continuing veterinary education, and marketing services.
As of September 30, 2022, the company operated in 31 provinces and 114 cities, with 23 pet hospital brands and 1,942 pet hospitals.
Financial Data
Source: New Ruipeng Prospectus
For the years 2020-2021, New Ruipeng's revenue was RMB 3.083 billion and RMB 4.784 billion (USD 673 million) respectively, with corresponding net losses of RMB 1.16 billion and RMB 1.372 billion (USD 184 million) during the same period.
For the nine months ended September 30, 2022, the company's revenue was RMB 4.315 billion (USD 607 million), compared to RMB 3.4 billion in the same period of the previous year, with corresponding net losses of RMB 756 million (USD 106 million) and RMB 867 million respectively.
Shareholding Structure
Source: New Ruipeng Prospectus
Before the IPO, Peng Yonghe, Chairman of New Ruipeng, held 31.8% of the shares, and Zhang Yanzhong held 2.2%.
Institutional investors: Hillhouse Capital holds 35.8% of the shares.
Originally published on 金盒企业管理集团




